These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
73 related articles for article (PubMed ID: 9372436)
1. A time-kill study to evaluate the in-vitro activity of clofazimine in combination with cefotaxime against a penicillin- and cefotaxime-resistant strain of Streptococcus pneumoniae. van Niekerk S; Huygens F; van Rensburg CE J Antimicrob Chemother; 1997 Oct; 40(4):602-4. PubMed ID: 9372436 [No Abstract] [Full Text] [Related]
2. Comparative activity of ampicillin, amoxycillin, amoxycillin/clavulanate and cefotaxime against 189 penicillin-susceptible and -resistant pneumococci. Pankuch GA; Jacobs MR; Appelbaum PC J Antimicrob Chemother; 1995 Jun; 35(6):883-8. PubMed ID: 7559200 [TBL] [Abstract][Full Text] [Related]
3. Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro. Lin E; Stanek RJ; Mufson MA Antimicrob Agents Chemother; 2003 Mar; 47(3):1151-3. PubMed ID: 12604560 [TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefepime and cefotaxime compared to six other agents against 350 penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Gomez-Lus R; Navarro C; Egido P; Aspiroz C; Goñi P; Vergara Y; Garcia C; Duran E; Castillo J; Rubio MC J Chemother; 2000 Feb; 12(1):17-21. PubMed ID: 10768511 [TBL] [Abstract][Full Text] [Related]
5. Synergy of cefotaxime and fosfomycin against penicillin-resistant pneumococci. Barakett V; Lesage D; Delisle F; Burghoffer B; Richard G; Vergez P; Petit JC J Antimicrob Chemother; 1993 Jan; 31(1):105-9. PubMed ID: 8444654 [TBL] [Abstract][Full Text] [Related]
6. In vitro interactions of LytA, the major pneumococcal autolysin, with two bacteriophage lytic enzymes (Cpl-1 and Pal), cefotaxime and moxifloxacin against antibiotic-susceptible and -resistant Streptococcus pneumoniae strains. Rodríguez-Cerrato V; García P; Del Prado G; García E; Gracia M; Huelves L; Ponte C; López R; Soriano F J Antimicrob Chemother; 2007 Nov; 60(5):1159-62. PubMed ID: 17827138 [TBL] [Abstract][Full Text] [Related]
7. Comparison of antibiotic combinations against penicillin-resistant pneumococci. Cassinat B; Nicolas MH J Antimicrob Chemother; 1994 Nov; 34(5):785-90. PubMed ID: 7706174 [TBL] [Abstract][Full Text] [Related]
8. Short-term bactericidal activity of amoxicillin and cefotaxime against penicillin-susceptible and -resistant pneumococcal strains: an in vitro pharmacodynamic simulation. Fenoll A; Casal J; Giménez MJ; Jado I; Aguilar L J Chemother; 2000 Apr; 12(2):124-8. PubMed ID: 10789550 [TBL] [Abstract][Full Text] [Related]
9. Time-kill studies of antibiotic combinations against penicillin-resistant and -susceptible Streptococcus pneumoniae. Friedland IR; Paris M; Shelton S; McCracken GH J Antimicrob Chemother; 1994 Aug; 34(2):231-7. PubMed ID: 7814283 [TBL] [Abstract][Full Text] [Related]
10. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin. Marton A; Major P Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796 [TBL] [Abstract][Full Text] [Related]
11. Time-kill studies of antimicrobial combinations including cefotaxime, ceftriaxone, vancomycin and meropenem against cephalosporin-resistant Streptococcus pneumoniae. Kim BN; Woo JH; Kim YS; Ryu J; Kim MN; Pai CH Chemotherapy; 2000; 46(5):303-8. PubMed ID: 10965094 [TBL] [Abstract][Full Text] [Related]
12. [In vitro bactericide activity of different antibiotic combinations to Streptococcus pneumoniae resistant to penicillin and cefotaxime]. Tubau F; Liñares J; Ardanuy C; Martínez-Lacasa J; Fernández A; Cabellos C; Fernández-Viladrich P; Martín R Enferm Infecc Microbiol Clin; 1996 Dec; 14(10):590-5. PubMed ID: 9053000 [TBL] [Abstract][Full Text] [Related]
13. Purulent pericarditis with associated cardiac tamponade caused by a Streptococcus pneumoniae strain highly resistant to penicillin, cefotaxime, and ceftriaxone. Saenz RE; Sanders CV; Aldridge KE; Patel MM Clin Infect Dis; 1998 Mar; 26(3):762-3. PubMed ID: 9524860 [No Abstract] [Full Text] [Related]
14. [In vitro comparative effect of cefixime and 7 other beta-lactamines against Streptococcus pneumoniae]. Boussougant Y; Weber P Presse Med; 1989 Oct; 18(32):1553-5. PubMed ID: 2530530 [TBL] [Abstract][Full Text] [Related]
15. Killing kinetics of vancomycin and rifampin tested alone and in combination against penicillin-resistant Streptococcus pneumoniae. Barakett V; Lesage D; Delisle F; Vergez P; Petit JC Eur J Clin Microbiol Infect Dis; 1993 Jan; 12(1):69-71. PubMed ID: 8462570 [No Abstract] [Full Text] [Related]
16. Non-Penicillin-Binding protein mediated high-level penicillin and cephalosporin resistance in a Hungarian clone of Streptococcus pneumoniae. Smith AM; Klugman KP Microb Drug Resist; 2000; 6(2):105-10. PubMed ID: 10990264 [TBL] [Abstract][Full Text] [Related]
17. In-vitro activity of cefditoren against clinical isolates of penicillin-susceptible and resistant strains of Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis. Fernández-Roblas R; López JC; Ramos JM; Gimeno M; Coronel P; Soriano F J Antimicrob Chemother; 1996 May; 37(5):1038-9. PubMed ID: 8737159 [No Abstract] [Full Text] [Related]